These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 19192640)
61. Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies. Hellyer JA; Gubens MA; Cunanan KM; Padda SK; Burns M; Spittler AJ; Riess JW; San Pedro-Salcedo M; Ramchandran KJ; Neal JW; Wakelee HA; Loehrer PJ Lung Cancer; 2019 Nov; 137():71-75. PubMed ID: 31557562 [TBL] [Abstract][Full Text] [Related]
62. Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract. Araki T; Takashima A; Hamaguchi T; Honma Y; Iwasa S; Okita N; Kato K; Yamada Y; Hashimoto H; Taniguchi H; Kushima R; Nakao K; Boku N; Shimada Y Anticancer Drugs; 2016 Sep; 27(8):794-9. PubMed ID: 27341105 [TBL] [Abstract][Full Text] [Related]
63. [Efficacy of Amrubicin Monotherapy for Patients with Extrapulmonary Neuroendocrine Carcinomas Refractory to Platinum-Based Chemotherapy]. Funasaka C; Kanemasa Y; Kageyama A; Shimoyama T; Omuro Y Gan To Kagaku Ryoho; 2020 Aug; 47(8):1205-1208. PubMed ID: 32829355 [TBL] [Abstract][Full Text] [Related]
64. Pharmacokinetics of amrubicin and its active metabolite amrubicinol in lung cancer patients. Matsunaga Y; Hamada A; Okamoto I; Sasaki J; Moriyama E; Kishi H; Matsumoto M; Hira A; Watanabe H; Saito H Ther Drug Monit; 2006 Feb; 28(1):76-82. PubMed ID: 16418698 [TBL] [Abstract][Full Text] [Related]
65. The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients. Miura S; Kaira K; Kaira R; Akamatsu H; Ono A; Shukuya T; Tsuya A; Nakamura Y; Kenmotsu H; Naito T; Murakami H; Takahashi T; Endo M; Yamamoto N Invest New Drugs; 2015 Jun; 33(3):755-60. PubMed ID: 25846908 [TBL] [Abstract][Full Text] [Related]
66. Interstitial lung disease associated with amrubicin chemotherapy in patients with lung cancer: a single institutional study. Miura Y; Saito Y; Atsumi K; Takeuchi S; Miyanaga A; Mizutani H; Minegishi Y; Noro R; Seike M; Shinobu K; Kubota K; Gemma A Jpn J Clin Oncol; 2016 Jul; 46(7):674-80. PubMed ID: 27162319 [TBL] [Abstract][Full Text] [Related]
67. Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer. Kitagawa C; Iwasaku M; Kogure Y; Ando M; Yoshioka H; Nishiyama A; Watanabe N; Kunimasa K; Tsubouchi K; Oka S; Saka H In Vivo; 2019; 33(1):163-166. PubMed ID: 30587617 [TBL] [Abstract][Full Text] [Related]
68. [A Case of Hypophosphatemia Induced by Administration of Amrubicin in a Patient with Small Cell Lung Cancer]. Sakurada H; Kawase Y; Mizuno H; Naito K; Yamamura M Gan To Kagaku Ryoho; 2018 Sep; 45(9):1369-1371. PubMed ID: 30237384 [TBL] [Abstract][Full Text] [Related]
69. Twisted tail: spinal epidural lipomatosis responding to chemotherapy in a patient with non-small-cell lung cancer. Nasoodi A; McAleese J; Grey A; Stranex S J Med Imaging Radiat Oncol; 2008 Oct; 52(5):525-6. PubMed ID: 19032401 [TBL] [Abstract][Full Text] [Related]
70. [A case of advanced small cell lung cancer complicated by chronic renal failure treated with amrubicin]. Isogai S; Totani Y; Kohashi Y; Mieno Y; Imizu H; Yoneda Y; Shimizu H; Hoshino T; Uchiyama Y; Takeuchi Y; Hayashi M; Saitoh Y; Sasaki F; Okazawa M; Sakakibara H Gan To Kagaku Ryoho; 2008 Sep; 35(9):1591-3. PubMed ID: 18799918 [TBL] [Abstract][Full Text] [Related]
71. Efficacy of S-1 monotherapy for non-small cell lung cancer after the failure of two or more prior chemotherapy regimens. Takakuwa O; Oguri T; Maeno K; Ozasa H; Iwashima Y; Miyazaki M; Kunii H; Takano Y; Mori T; Sato S; Ueda R Oncol Lett; 2010 Jan; 1(1):147-150. PubMed ID: 22966273 [TBL] [Abstract][Full Text] [Related]
72. Amrubicin: a synthetic anthracyclin analogue in the treatment of extensive stage small cell lung cancer. Shah CM Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):241-5. PubMed ID: 19538159 [TBL] [Abstract][Full Text] [Related]
73. Thymic small cell carcinoma shows marked response to amrubicin. Igawa S; Murakami H; Yamamoto N J Thorac Oncol; 2009 Jun; 4(6):778. PubMed ID: 19461410 [No Abstract] [Full Text] [Related]
74. Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma. Sakaida E; Ebata T; Iwasawa S; Kurimoto R; Yonemori S; Ota S; Nakatani Y; Sekine I; Takiguchi Y Intern Med; 2017; 56(5):567-570. PubMed ID: 28250307 [TBL] [Abstract][Full Text] [Related]
75. [The effect of chemotherapy treatment on hemostasis of patients with lung cancer]. Vorob'eva EO; Akhvlediani M; Emukhvari MG; Sharashidze NA; Gzirishvili LM Georgian Med News; 2008 Sep; (162):40-6. PubMed ID: 18830029 [TBL] [Abstract][Full Text] [Related]
76. Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer. Kasajima M; Igawa S; Ishihara M; Otani S; Takakura A; Yokoba M; Kubota M; Sasaki J; Katagiri M; Masuda N Oncol Lett; 2017 Mar; 13(3):1719-1724. PubMed ID: 28454315 [TBL] [Abstract][Full Text] [Related]
77. Small-cell lung cancer responds to amrubicin. Bosch X Lancet Oncol; 2007 Jan; 8(1):13. PubMed ID: 17354304 [No Abstract] [Full Text] [Related]
78. A Case of Duodenal Neuroendocrine Carcinoma Treated with Amrubicin as Second-line Chemotherapy. Inoue T; Sano H; Mizushima T; Nishie H; Iwasaki H; Okumura F J Gastrointestin Liver Dis; 2015 Sep; 24(3):379-82. PubMed ID: 26405711 [TBL] [Abstract][Full Text] [Related]
79. [Advances on treatment of small cell lung cancer with amrubicin]. Lu H; Chen L; Cai J; Ma S Zhongguo Fei Ai Za Zhi; 2010 May; 13(5):544-9. PubMed ID: 20677657 [No Abstract] [Full Text] [Related]
80. Small cell carcinoma of the prostate treated with amrubicin. Katou M; Soga N; Onishi T; Arima K; Sugimura Y Int J Clin Oncol; 2008 Apr; 13(2):169-72. PubMed ID: 18463964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]